Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications-Reply

被引:0
|
作者
Dixit, Anjali A. [1 ,2 ]
Bateman, Brian T. [1 ]
Sun, Eric C. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA USA
[2] Dept Anesthesiol Perioperat & Pain Med, 300 Pasteur Dr, Stanford, CA 94305 USA
来源
关键词
PULMONARY ASPIRATION;
D O I
10.1001/jama.2024.10032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [22] Postoperative Aspiration Pneumonia Among Adults Using GLP-1 Receptor Agonists
    Chen, Yuan-Hsin
    Zink, Thomas
    Chen, Ya-Wen
    Nin, Darren Z.
    Talmo, Carl T.
    Hollenbeck, Brian L.
    Grant, Andrew R.
    Niu, Ruijia
    Chang, David C.
    Smith, Eric L.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [23] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [25] The effect of GLP-1 receptor agonists on targets for cardiovascular risk reduction
    Westrick, Christopher
    Snider, Melissa
    Arradaza, Nicole
    Sharma, Kavita
    PHARMACOTHERAPY, 2013, 33 (10): : E190 - E190
  • [26] Methodology of Study on GLP-1 Receptor Agonists and Hepatocellular Carcinoma Risk
    Wei, James Cheng-chung
    Kuo, Poi
    Mei, Qi
    GASTROENTEROLOGY, 2025, 168 (02) : 422 - 422
  • [27] GLP-1 receptor agonists: fighting obesity with an eye to cardiovascular risk
    Liuzzo, Giovanna
    Galiuto, Leonarda
    EUROPEAN HEART JOURNAL, 2021, 42 (17) : 1652 - 1653
  • [28] GLP-1 Receptor Agonists' Role in Reducing Hepatocellular Carcinoma Risk
    Liu, Zaoqu
    Shan, Dan
    Han, Xinwei
    GASTROENTEROLOGY, 2025, 168 (02) : 422 - 423
  • [29] GLP-1 receptor agonists and cardiovascular risk in routine clinical practice
    Schernthaner, Guntram
    Schernthaner-Reiter, Marie Helene
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (02): : 78 - 80
  • [30] The Cardiovascular Effects of GLP-1 Receptor Agonists
    Okerson, Theodore
    Chilton, Robert J.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e146 - e155